Matthew R. Schaab
Papers
1
Total Citations
52
H-Index
1
About
Matthew R. Schaab is a leading researcher in clinical mass spectrometry, with a primary focus on advancing high-throughput quantitative analysis of peptide biomarkers. His most cited work, a 2014 study on insulin-like growth factor 1 (IGF1), introduced a parallel workflow for mass spectrometric immunoassay capable of processing over 1,000 samples per day—a transformative leap for clinical diagnostics. This contribution directly addresses the critical bottleneck of throughput that has historically hindered the adoption of mass spectrometry in routine clinical settings, particularly for managing growth hormone disorders where IGF1 is a key biomarker. By demonstrating a practical, scalable solution for MS-based IGF1 detection, Schaab’s research has helped pave the way for more precise and efficient biomarker analysis. His work, cited 52 times, underscores his impact on bridging the gap between advanced analytical techniques and real-world clinical applications, making him a notable figure in the evolution of diagnostic mass spectrometry.
Research Focus
Key Achievements
Top Papers
- 1